Five prime therapeutics, inc. (FPRX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-33,443

-

-19,414

-13,137

-13,040

296,128

-23,971

-11,474

-11,036

-11,826

-7,088

-9,866

-8,644

-7,317

-7,234

-7,274

-7,047

Net loss

-20,116

-31,357

-36,069

-34,391

-35,385

-38,753

-47,244

-34,060

-20,390

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,292

1,450

1,186

1,333

1,331

1,271

1,273

1,305

1,151

769

619

597

515

509

451

407

375

403

452

423

400

398

382

381

391

406

433

430

425

Impairment of fixed assets

-190

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-33

0

0

-5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

4,482

3,424

8,656

5,863

4,872

6,579

7,634

7,435

7,820

7,461

7,064

9,761

9,887

10,047

8,311

7,126

7,401

6,411

2,853

1,212

991

-

-

-

-

-

-

-

-

Amortization of discounts and premiums on marketable securities

145

238

479

668

778

766

648

349

-13

-154

-244

-515

-708

-848

-993

-1,227

-1,119

-534

-449

-508

-534

-

-

-

-

-

-

-

-

Non-cash operating lease expense

631

612

596

580

563

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

80

135

285

Excess tax benefits from employee equity incentive plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,785

-1,871

1,300

1,233

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

5,327

6,293

1,682

1,769

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

740

636

-

519

411

624

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

417

211

-

63

107

102

Changes in operating assets and liabilities:
Receivables from collaborative partners

-1,931

433

1,062

-761

-1,733

81

2,304

-1,558

-8,864

8,777

524

-2,077

1,950

1,652

-1,092

1,639

-2,294

2,388

948

585

-277

319

-86

-110

-9

-87

241

115

-370

Income tax receivable

-

-

-

-

-

-

-

-

-

0

0

-4,677

7

1,477

1,689

682

822

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid, other current assets and other long-term assets

-2,254

-1,387

-5,421

2,429

-2,421

7,105

-798

-1,454

5,267

-2,344

-528

90

-1,453

1,971

1,798

-14

-756

1,292

2,853

-52

689

40

506

92

-59

979

-155

155

2

Accounts payable

-388

-3,050

719

-921

3,180

-523

29

635

-406

-652

1,568

514

473

-194

-126

-366

-874

329

212

449

-192

377

-95

420

-1

-676

680

161

-374

Accrued personnel-related expenses

-2,679

811

2,407

122

-3,918

569

1,695

931

-2,968

954

825

1,699

-4,279

2,026

1,916

167

-3,030

2,598

1,186

426

-1,950

1,512

787

554

-1,192

861

421

510

-1,085

Deferred revenue

-1,480

-767

-938

-650

-3,129

-1,195

-1,069

-5,102

-2,304

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-3,465

-3,183

-

-3,936

-3,970

-4,648

-8,515

-2,109

-1,247

82

27,970

-2,100

18,043

1,617

-2,397

-1,551

-2,216

6,444

Deferred rent

-

-

-

-

-

-224

-224

625

625

1,183

1,331

1,401

-216

-192

-193

-191

-192

-167

-168

-128

-50

-137

-137

-137

-138

58

63

63

63

Income tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,313

-10,950

-8,213

-22,367

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities, and other long-term liabilities

322

-2,524

-7,439

7,613

-3,349

-12,403

9,127

-2,813

2,235

-

-

-

2,113

5,202

1,497

3,826

-1,616

1,776

615

705

1,081

-

-

-

-

-

-

-

-

Operating lease liabilities

-986

-906

-915

-867

-217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities and other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,479

1,461

-

-346

-280

644

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-27,929

-

-15,664

-15,058

-34,108

333,588

-24,279

-9,659

-10,552

18,703

-9,896

12,049

-5,591

-

-

-

-

Net cash used in operating activities

-15,072

-29,619

-27,917

-23,654

-32,676

-52,578

-30,933

-28,381

-10,622

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,493

-121

Investing activities
Purchases of marketable securities

25,335

12,512

55,463

65,374

59,714

94,922

70,296

58,190

153,957

11,499

98,212

94,951

125,701

105,797

71,075

239,215

100,665

322,682

32,382

9,118

93,876

37,658

14,565

38,067

68,384

67,698

501

8,571

3,006

Maturities of marketable securities

52,605

49,223

94,650

97,642

79,500

127,200

113,500

82,250

63,250

62,500

104,750

136,500

205,750

75,000

116,750

156,000

118,250

101,000

73,750

23,000

24,500

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,400

18,500

-

10,750

8,810

9,875

Purchases of property and equipment

29

198

-58

653

983

184

414

9,893

840

1,314

1,046

757

1,824

840

253

1,045

823

912

98

980

436

213

445

689

296

174

109

231

293

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

78,225

-

45,422

-84,260

16,762

-222,594

41,270

12,902

-69,812

-17,621

9,795

-11,356

-50,180

-

-

-

-

Net cash provided by investing activities

27,241

36,513

39,245

31,615

18,803

32,094

42,790

14,167

-91,547

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

6,576

Financing activities
Proceeds from public offering of common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

40,104

-

-

-

-

Proceeds from public offering of common stock, net of issuance costs

-

-

-

-

-

-1

0

0

107,613

-

-

-

-

-

-

-

-

0

0

0

78,693

18,629

21,470

-10

18,639

-

-

-

-

Excess tax benefits from employee equity incentive plans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,871

1,300

1,233

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

349

1,182

1,048

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

Proceeds from issuance of common stock under equity incentive plans

-

138

5

771

222

940

160

1,159

1,704

-

-

-

-

1,621

786

3,161

2,755

-

-

-

886

1,041

170

701

547

-

-

-

-

Repurchase of shares to satisfy tax withholding obligations

277

165

706

58

670

547

757

101

997

325

1,398

373

11,813

0

10,452

0

3,602

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-277

-27

-701

713

-448

392

-597

1,058

108,320

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-478

12

Net increase (decrease) in cash and cash equivalents and restricted cash

11,892

6,867

10,627

8,674

-14,321

-20,092

11,260

-13,156

6,151

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure
Payments under capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

4

4

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-10,765

-

-11,537

4,461

386

2,021

869

1,371

79,579

1,057

170

686

59,290

-

-

-

-

Net increase in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

39,531

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,268

0

0

14,701

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment purchases included in accrued liabilities

-

0

-28

-435

492

584

108

-507

531

7,820

810

-1,145

1,548

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information
Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,221

-94,857

-16,960

113,015

17,860

4,614

-785

2,139

69

1,379

3,519

-69,487

68,753

-8,963

6,467